Skip to main content
. 2021 Jan 13;11:1032. doi: 10.1038/s41598-020-80327-9

Figure 6.

Figure 6

(A–E) The MTT assay for relative cell viabilities of the MDA-MB-231 breast cancer cells and HBL-100 normal breast cells incubated with rapid synthesized SeNPs for 48 h. Microscopic images of with and without SeNPs treated cells [(A,C) HBL-100 normal cell; (B,D) MDA-MB-231 cell].